BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9689077)

  • 21. Effects of arenastatin A and its synthetic analogs on microtubule assembly.
    Koiso Y; Morita K; Kobayashi M; Wang W; Ohyabu N; Iwasaki S
    Chem Biol Interact; 1996 Dec; 102(3):183-91. PubMed ID: 9021170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells.
    Lu K; Dempsey J; Schultz RM; Shih C; Teicher BA
    Cancer Chemother Pharmacol; 2001; 47(2):170-8. PubMed ID: 11269744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate.
    Ray A; Okouneva T; Manna T; Miller HP; Schmid S; Arthaud L; Luduena R; Jordan MA; Wilson L
    Cancer Res; 2007 Apr; 67(8):3767-76. PubMed ID: 17440090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24.
    Vidya R; Eggen M; Georg GI; Himes RH
    Bioorg Med Chem Lett; 2003 Feb; 13(4):757-60. PubMed ID: 12639575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.
    Panda D; Miller HP; Islam K; Wilson L
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10560-4. PubMed ID: 9380674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
    Bai R; Durso NA; Sackett DL; Hamel E
    Biochemistry; 1999 Oct; 38(43):14302-10. PubMed ID: 10572005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine.
    Toso RJ; Jordan MA; Farrell KW; Matsumoto B; Wilson L
    Biochemistry; 1993 Feb; 32(5):1285-93. PubMed ID: 8448138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
    Mohan R; Panda D
    Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation.
    Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D
    Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of vinblastine on polymerization and dynamics at opposite microtubule ends.
    Panda D; Jordan MA; Chu KC; Wilson L
    J Biol Chem; 1996 Nov; 271(47):29807-12. PubMed ID: 8939919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
    Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
    J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
    Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
    Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.
    Wilson L; Panda D; Jordan MA
    Cell Struct Funct; 1999 Oct; 24(5):329-35. PubMed ID: 15216890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
    Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
    Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
    Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
    Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A; Sept D
    Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enantioselective synthesis of (+)-cryptophycin 52 (LY355703), a potent antimitotic antitumor agent.
    Ghosh AK; Swanson L
    J Org Chem; 2003 Dec; 68(25):9823-6. PubMed ID: 14656116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin.
    Cruz-Monserrate Z; Vervoort HC; Bai R; Newman DJ; Howell SB; Los G; Mullaney JT; Williams MD; Pettit GR; Fenical W; Hamel E
    Mol Pharmacol; 2003 Jun; 63(6):1273-80. PubMed ID: 12761336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: A possible mechanistic basis for its anticancer activity.
    Ashraf SM; Mahanty S; Rathinasamy K
    Life Sci; 2021 Dec; 287():120105. PubMed ID: 34756929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
    Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
    J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.